Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2012
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324216 Substituted piperazines
12/04/2012US8324213 Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
12/04/2012US8324203 Azadecalin glucocorticoid receptor modulators
12/04/2012US8324200 Compositions and methods for inhibition of the JAK pathway
12/04/2012US8324198 Monocarbams
12/04/2012US8324186 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
12/04/2012CA2674543C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/04/2012CA2622760C Cyclopropyl amines as modulators of the histamine h3 receptor
12/04/2012CA2600203C New salt and polymorphs of a dpp-iv inhibitor
12/04/2012CA2590204C Amide compounds and thrombopoietin receptor activators
12/04/2012CA2561313C Methods for minimizing thioamide impurities
11/2012
11/29/2012WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof
11/29/2012WO2012162365A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012160392A1 Morpholino compounds, uses and methods
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012159992A1 Process for obtaining rivaroxaban and intermediate thereof
11/29/2012WO2012159666A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases
11/29/2012WO2012087976A3 Novel inhibitors of hepatitis c virus replication
11/29/2012US20120302751 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
11/29/2012US20120302746 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
11/29/2012US20120302745 Exo-selective synthesis of himbacine analogs
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302606 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302566 Indanyloxydihydrobenzofuranylacetic acids
11/29/2012US20120302563 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
11/29/2012US20120302562 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use
11/29/2012US20120302558 Oxazine derivatives and their use in the treatment of neurological disorders
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302524 1,3,4-oxadiazole-2-carboxamide compound
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof
11/29/2012CA2837027A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/28/2012EP2527343A1 Heterocyclic compound having azole group
11/28/2012EP2527339A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
11/28/2012EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
11/28/2012EP2527328A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2526098A1 Nitrogen-containing heteroaryl derivatives
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012EP2526090A2 New anti-malarial agents
11/28/2012CN102803257A Insecticidal Compounds
11/28/2012CN102803256A Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives
11/28/2012CN102803255A Novel GPR 119 agonists
11/28/2012CN102803252A Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
11/28/2012CN102803237A Oxazole and thiazole derivatives as alx receptor agonists
11/28/2012CN102803235A Compounds which selectively modulate the CB2 receptor
11/28/2012CN102803227A Morpholinylquinazolines
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102803225A Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803214A New compounds, pharmaceutical composition and methods relating thereto
11/28/2012CN102796095A Tetrahydroquinoline analogues as muscarinic agonists
11/28/2012CN102796092A Oxazolidinone derivative, and preparation method and application thereof
11/28/2012CN102796091A Substituted oxazolidinone compound and preparation method and application thereof
11/28/2012CN102796090A Method for preparing iloperidone
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/28/2012CN101868458B Isoxazolo-pyridazine derivatives
11/28/2012CN101827841B (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
11/28/2012CN101641350B Dibenzo[b, f][1, 4]oxazapine compounds
11/27/2012US8318952 Substituted indole derivatives for the treatment of respiratory diseases
11/27/2012US8318951 Stem cell differentiating agents and uses therefor
11/27/2012US8318944 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/27/2012US8318791 Substituted imidazole derivatives
11/27/2012US8318783 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/27/2012US8318776 Pyridine compound, pesticidal composition and method of controlling pests
11/27/2012US8318757 Substituted isoxazoline compound and pest control agent
11/27/2012US8318754 Pyrimidinecarboxamide derivatives
11/27/2012US8318750 Organic compounds
11/27/2012US8318737 Compounds and compositions for treating cancer
11/27/2012US8318736 HIV inhibiting 5,6-substituted pyrimidines
11/27/2012US8318735 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318719 Inhibitors of Bruton's tyrosine kinase
11/27/2012US8318718 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2629570C Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
11/27/2012CA2579002C Pyridyl inhibitors of hedgehog signalling
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2531766C Entry inhibitors of the hiv virus
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012158399A1 Condensed 2 - carbamoylpyridazinones as potassium channel modulators
11/22/2012WO2012158396A1 Parasiticidal dihydroisoxazole compounds
11/22/2012WO2012158117A1 Combination therapies for treating pain
11/22/2012WO2012157288A1 Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
11/22/2012WO2012156983A1 Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012156284A1 1,3-oxazines as bace1 and/or bace2 inhibitors
11/22/2012WO2012155352A1 Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012WO2012112440A3 Fluorescent potassium ion sensors
11/22/2012WO2012100229A3 Compositions and methods for cardiovascular disease
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 647